Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia

116Citations
Citations of this article
144Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Second malignant neoplasms (SMNs) after diagnosis of childhood acute lymphoblastic leukemia (ALL) are rare events. Patients and Methods: We analyzed data on risk factors and outcomes of 642 children with SMNs occurring after treatment for ALL from 18 collaborative study groups between 1980 and 2007. Results: Acute myeloid leukemia (AML; n 186), myelodysplastic syndrome (MDS; n 69), and nonmeningioma brain tumor (n 116) were the most common types of SMNs and had the poorest outcome (5-year survival rate, 18.1% ± 2.9%, 31.1% ± 6.2%, and 18.3% ± 3.8%, respectively). Five-year survival estimates for AML were 11.2% ± 2.9% for 125 patients diagnosed before 2000 and 34.1% ± 6.3% for 61 patients diagnosed after 2000 (P

Cite

CITATION STYLE

APA

Schmiegelow, K., Levinsen, M. F., Attarbaschi, A., Baruchel, A., Devidas, M., Escherich, G., … Valsecchi, M. G. (2013). Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 31(19), 2469–2476. https://doi.org/10.1200/JCO.2012.47.0500

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free